Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 13/20 | 0.39 |
| ▸ | CA2 | P00918 | 13/20 | 0.39 |
| ▸ | EYA2 | O00167 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | MVD | P53602 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Creatine SCHEMBL21567 | 0.98 | — | — | |
| Creatine SCHEMBL4007614 | 0.98 | NOS3 (0.46) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL27979093 | 0.98 | NOS3 (0.46) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL30063981 | 0.98 | — | — | |
| Creatine SCHEMBL1241423 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL21810557 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL53010 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL20497169 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL21404054 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL5326455 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107383090-B | A kind of synthesis technology of Creatine Phosphate Sodium | 泰山医学院 | 2019-09-17 | — | — | CN | claimed |
| CN-109152810-A | Methods and compositions for preventing and treating duchenne muscular dystrophy | 康德生物医疗技术公司 | 2019-01-04 | — | — | CN | claimed |
| CN-107383090-A | A kind of synthesis technique of Creatine Phosphate Sodium | 泰山医学院 | 2017-11-24 | — | — | CN | claimed |
| CN-106011163-A | Method for cell-free expression of signal protein and expression system | 武汉华美生物工程有限公司 | 2016-10-12 | — | — | CN | claimed |
| CN-110408635-A | A kind of application of the nucleic acid constructs containing Streptavidin element in protein expression, purifying | KANGMA SHANGHAI BIOTECHNOLOGY CO LTD | 2019-11-05 | — | — | CN | disclosed |
| CN-110325641-A | The Cell free expression system of energy regeneration based on inorganic polyphosphate | 耐特希生物有限公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-107383090-B | A kind of synthesis technology of Creatine Phosphate Sodium | 泰山医学院 | 2019-09-17 | — | — | CN | disclosed |
| CN-107383090-B | A kind of synthesis technology of Creatine Phosphate Sodium | 泰山医学院 | 2019-09-17 | — | — | CN | disclosed |
| CN-108949801-B | A method of by knocking out nucleic acid enzyme system to regulate and control external biological synthesizing activity | 康码（上海）生物科技有限公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-109841278-A | A method of the screening of coronary disease disease is carried out with angiocarpy mark and rote learning operation method | 长庚医疗财团法人林口长庚纪念医院 | 2019-06-04 | — | — | CN | disclosed |
| CN-109837293-A | A kind of series connection DNA element that can enhance protein synthesis efficiency | 康码（上海）生物科技有限公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-109154001-A | Novel minimal UTR sequences | 埃泽瑞斯公司 | 2019-01-04 | — | — | CN | disclosed |
| CN-102014980-A | Devices and methods for treating central nervous system pathologies | UNIV WAKE FOREST HEALTH SCIENCES | 2011-04-13 | — | — | CN | disclosed |
| EP-2237812-A1 | DEVICE AND METHOD FOR TREATING CENTRAL NERVOUS SYSTEM PATHOLOGY | Wake Forest University Health Sciences (US) | 2010-10-13 | — | — | EP | disclosed |
| CN-101084937-B | Ginkgo leaves freezing-dried powder injection and preparation method thereof | ZHENBAODAO PHARMACEUTICAL CO LTD HEILONGJIANG PROV | 2010-06-30 | — | — | CN | disclosed |
| US-20090254120-A1 | DEVICE AND METHOD FOR TREATING CENTRAL NERVOUS SYSTEM PATHOLOGY | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2009-10-08 | — | — | US | disclosed |
| WO-2009089435-A1 | DEVICE AND METHOD FOR TREATING CENTRAL NERVOUS SYSTEM PATHOLOGY | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2009-07-16 | — | — | WO | disclosed |
| CN-101084937-A | Ginkgo leaves freezing-dried powder injection and preparation method thereof | HEILONGJIANG ZHENBAODAO PHARMA (CN) | 2007-12-12 | — | — | CN | disclosed |
| US-5130119-A | Sulfonamide or hydroxy fluorine substituted benzene for medical diagnosis | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-07-14 | — | — | US | disclosed |
| US-4959612-A | Method of heteronuclear decoupling in magnetic resonance spectroscopy, and device for determining a spectrum | U.S. PHILIPS CORPORATION (US) | 1990-09-25 | — | — | US | disclosed |